Health Care & Life Sciences » Pharmaceuticals | Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
516.00
673.00
-
0.20
77.00
96
Gross Income
516.00
673.00
-
0.20
77.00
96
SG&A Expense
87,043.00
83,278.00
3,170.90
24,981.50
31,809.00
40,360
EBIT
87,559.00
83,951.00
-
24,981.60
31,886.00
40,456
Unusual Expense
-
-
62.00
242.00
176.00
226
Non Operating Income/Expense
-
-
-
-
350.00
200
Interest Expense
2,633.00
2,210.00
3,611.90
1,212.50
-
-
Pretax Income
90,192.00
86,161.00
6,844.90
26,387.90
31,154.00
32,811
Consolidated Net Income
90,192.00
86,161.00
6,844.90
26,387.90
31,154.00
32,811
Net Income
90,192.00
86,161.00
6,844.90
26,387.90
31,154.00
32,811
Net Income After Extraordinaries
90,192.00
86,161.00
6,844.90
26,387.90
31,154.00
32,811
Net Income Available to Common
90,192.00
86,161.00
6,844.90
26,387.90
31,154.00
32,811
EPS (Basic)
44.48
30.62
1,401.05
5.07
2.54
2.22
Basic Shares Outstanding
2,027.90
2,814.00
4.90
5,204.60
12,244.90
14,796.70
EPS (Diluted)
44.48
30.62
1,400.90
5.07
2.54
2.22
Diluted Shares Outstanding
2,027.90
2,814.00
4.90
5,204.60
12,244.90
14,796.70
EBITDA
87,043.00
83,278.00
3,170.90
24,981.50
31,809.00
40,360
Non-Operating Interest Income
-
-
-
48.30
558.00
7,671

About Madrigal Pharmaceuticals

View Profile
Address
200 Barr Harbor Drive
West Conshohocken Pennsylvania 19428
United States
Employees -
Website http://www.madrigalpharma.com
Updated 07/08/2019
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.